US 10287286
Compounds
granted A61PA61P13/12A61P43/00
Quick answer
US patent 10287286 (Compounds) held by Takeda Pharmaceutical Company Limited expires Mon May 09 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue May 14 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 09 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61P, A61P13/12, A61P43/00, A61P9/00, A61P9/04